Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain

Most IDH mutant gliomas harbor either 1p/19q co-deletions or TP53 mutation; 1p/19q co-deleted tumors have significantly better prognoses than tumors harboring TP53 mutations. To investigate the clinical factors that contribute to differences in tumor progression of IDH mutant gliomas, we classified...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakae, Shunsuke, Kato, Takema, Murayama, Kazuhiro, Sasaki, Hikaru, Abe, Masato, Kumon, Masanobu, Kumai, Tadashi, Yamashiro, Kei, Inamasu, Joji, Hasegawa, Mitsuhiro, Kurahashi, Hiroki, Hirose, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689569/
https://www.ncbi.nlm.nih.gov/pubmed/29156679
http://dx.doi.org/10.18632/oncotarget.20951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689569/
https://www.ncbi.nlm.nih.gov/pubmed/29156679
http://dx.doi.org/10.18632/oncotarget.20951

Ejemplares similares